Anthropic wants everyday investors to be part of its IPO. Some are not buying it.
By William Gavin, Hannah Pedone and Christine Ji
'It's total hype and kind of inflated expectations'
Anthropic is just days away from a highly anticipated initial public offering, which could be a shot in the arm for the artificial-intelligence trade. It's counting on retail investors to chip in, but not everyone is fully on board.
"You know, it's total hype and kind of inflated expectations ... It doesn't pass the sniff test," said Colin Rand, a 52-year-old executive at a cybersecurity company. However, "I do believe it's too big to fail," he said.
Rand is one of many individual investors considering buying Anthropic (ANT) stock in its public debut, which could come as soon as Thursday. At the company's declared price range of $70 to $78 a share, Anthropic could be valued at more than $1 trillion following its IPO.
"I think it is probably impossible to value the technology right now. And so it's just really a question of what people are willing to pay for it," said Rand, who told MarketWatch he's planning to buy hundreds of shares in Anthropic's IPO.
"I'd rather own a piece of Skynet than not," he added, referring to the fictional AI antagonist of the Terminator film franchise. In its IPO prospectus filing, Anthropic warned that AI systems could pose "catastrophic or existential risks to humanity" and highlighted the risks associated with the technology it has monetized.
Following SpaceX's (SPCX) lead, Anthropic wants retail investors to play a bigger role than usual in its IPO. It expects to allocate about 20% of its Class A common shares to smaller investors through a number of broker-dealers, including Fidelity, SoFi, Charles Schwab and Morgan Stanley's E*trade, according to its latest prospectus.
Investors seeking an allocation aren't guaranteed the number of shares they want, or even any stock at all. The IPO is six times oversubscribed, meaning demand is far beyond supply, Bloomberg has reported, citing people familiar with the matter.
Several brokers also have restrictions on who can participate. Both Sofi and Morgan Stanley, for example, said "flipping" shares within the first 30 days after an IPO may impact an investor's eligibility for future offerings.
Such rules won't prevent early selling, according to projections. Based on recent pre-IPO perpetual futures trading on the platform Hyperliquid, Vanda Research estimates that there could be $1.4 billion in gross retail turnover on the day Anthropic lists on Nasdaq, more than SpaceX or SK Hynix (KR:000660).
Early trading, combined with a day-one unlock of up to 316 million insider-held shares, could spark volatility that can weigh on the stock. And poor early performance is already fairly common with big IPOs. Meta Platforms (META), then Facebook, stock fell 18% in its first month on the market. Shares of Arm (ARM) and SpaceX dropped 20% and 13%, respectively, a month after their IPOs.
From the archives (June 2026): Looking to buy into the SpaceX IPO? This scary chart might make you think twice.
Poor short-term performance is why some investors steer clear of IPOs. Bill Gunderson, a partner at GCG Advisory Partners, pointed to the Renaissance IPO ETF IPO, which has underperformed the S&P 500 in 2026 and has been on a losing streak ahead of Anthropic's debut.
SpaceX "has the greatest promoter of all time behind it ... Elon Musk, and he can't prop it up," Gunderson said of the company's stock performance after the biggest IPO on record. He said he wouldn't invest in Anthropic, saying that CEO Dario Amodei lacks Musk's "promotional pizazz," and pointing to the company's high spending plans and unprofitability.
Some retail investors agree. Tom Edgar, a 63-year-old retired web developer, said he's "steering clear" of the Anthropic IPO, adding that the frenzy surrounding the listing has left him "befuddled."
Edgar is sticking to a picks-and-shovels investment strategy he's followed for over a decade. As chip stocks pulled back in recent months from macroeconomic headwinds and AI jitters, Edgar has taken it as a buying opportunity. He's increased his positions in chip-equipment makers Applied Materials (AMAT) and KLA Corp (KLAC), as well as flash memory provider Sandisk (SNDK).
"I've added to my silicon-related holdings on the dip, but I dislike LLMs and am not invested in them apart from silicon," Edgar said.
Gurtej Gill, a retail investor, told MarketWatch that he thinks Anthropic's IPO is one of the "most extraordinary business stories" in artificial intelligence.
However, a "great business doesn't always translate into a great investment," he said, adding it's "especially at such an aggressive valuation."
He said he's "bullish" on Anthropic's potential, but added, "I'm not restructuring my portfolio around the IPO."
"I'd rather wait for a valuation that makes sense than chase the hype," he said.
Others are more optimistic. Akshay Asok, a business-systems analyst, told MarketWatch that he plans to make Anthropic the first IPO he's ever participated in.
Asok, 34, who said he has invested in companies like Microsoft (MSFT), Cloudflare (NET) and Nvidia (NVDA), plans to reallocate a "massive amount" of his portfolio to get a "high six figures" allocation, if he can swing it. He said a "selling point" for him was that Anthropic's seven co-founders will retain control of the company due to a unique equity structure.
Janice Quek, an analyst at CFRA, said in a client note that the structure effectively gives investors "full economic risk while ceding virtually all governance rights to insiders." Since Anthropic is registered as a public-benefit corporation, it has a mandate to serve the interests of shareholders, users and the public at large. Quek said it may make decisions that negatively affect its business.
Asok and investors like him may be OK with that.
"The whole mission is a race toward achieving [artificial general intelligence] while doing it safely, and these [seven] truly believe that they can do it," Asok said over email. "[T]heir commitment to the mission has never wavered."
That said, like any IPO, investors should "do their own homework," said Sagiv Ofek, an engineering head at the software firm Postman.
"As for Anthropic, I'd ask myself: Do I use their products? Do I believe they can 10x from here given the market conditions and competition? If the answer is yes, I should buy it," he said.
-William Gavin -Hannah Pedone -Christine Ji
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-17-26 1001ET
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

This Newly Undervalued Stock Has Plenty of Growth Ahead

7 Undervalued Stocks That Crushed Earnings

Retirees: 5 Reasons to Consider Index Funds and ETFs

5 Stocks to Buy After Earnings

